Johnson & Johnson
Johnson & Johnson is a leading US-based global healthcare company focused on developing and providing innovative pharmaceuticals and medical technology solutions. The company is dedicated to advancing global human health, sustainably optimizing patient lives, and enhancing quality of life through its cutting-edge products and therapies.
Recap: the latest results
Johnson & Johnson (JNJ) reported its Q3 2026 financial results on October 13, 2026, before market open. The company posted earnings per share of 2.59 USD, beating the analyst estimate of 2.52 USD by 2.7%. Reported revenue stood at 25,399 million USD. Following the release, the stock price reacted with a decline of 5.73%.
Generated automatically from our data — as of 10/15/2026 Read the article →
Frequently asked questions
When did Johnson & Johnson last report quarterly earnings?
Johnson & Johnson last reported quarterly earnings on 10/13/2026 (Q3 2026). Earnings per share (EPS) came in at 2.59 USD.
How does Johnson & Johnson stock react to earnings?
Across its last 5 earnings reports, Johnson & Johnson stock moved by ±1.1% on average the following day. The largest reaction was -2.7% on 07/15/2026; 1 of 5 reactions were positive.
How often has Johnson & Johnson beaten expectations?
Johnson & Johnson has beaten analyst EPS estimates in 5 of its last 6 evaluated quarters (beat rate: 83.3%).
How do I add the Johnson & Johnson earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
In the earnings calendar
Earnings statistics
Stock reaction to earnings
Basis: price reactions to the last 5 report dates (close to close).
Estimates vs. results
Basis: 6 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.